PULSATILE DRUG DELIVERY: A STRATEGY FOR TREATING CHRONOTHERAPEUTIC AILMENTS
DOI:
https://doi.org/10.22159/ijcpr.2023v15i4.3012Keywords:
Pulsatile system of drug delivery, Chronotherapeutic ailments, Circadian cycleAbstract
Modern drug delivery systems have been promoted to a unique notion of chronopharmacology, i.e., the ability to provide the medicament to a patient in a staggered profile, as the discipline of chronobiology has advanced. The main disadvantage of developing such a delivery system that fits the circadian cycle is the lack of accurate technology (Pulsatile drug delivery system, PDDS). Pulsatile devices are gaining popularity because they deliver the medicine to the correct region of action at the correct time, allowing for spatial and temporal dosing and compliance among patients. These technologies are meant to work with the body's natural circadian cycle. The circadian rhythm affects various biological systems in humans, including metabolism, physiology, behaviour, sleep patterns, hormone synthesis, and so on. This article addresses several methods, such as osmotic systems, capsular systems, single and multiple-unit programable devices that rely on soluble or erodible polymer coatings, and the usage of rupturable membranes. The present review covered the rationale for the creation of pulsatile drug delivery systems, benefits, limitations the types of diseases that require pulsatile release, categorization, and assessments of pulsatile system of drug delivery.
Downloads
References
Jain D, Raturi R, Jain V, Bansal P, Singh R. Recent technologies in pulsatile drug delivery systems. Biomatter. 2011;1(1):57-65. doi: 10.4161/biom.1.1.17717, PMID 23507727.
Bussemer T, Peppas NA, Bodmeier R. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur J Pharm Biopharm. 2003;56(2):261-70. doi: 10.1016/s0939-6411(03)00070-5, PMID 12957641.
Pozzi F, Furlani P, Gazzaniga A, Davis SS, Wilding IR. The time clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J Control Release. 1994;31(1):99-108. doi: 10.1016/0168-3659(94)90255-0.
Youan BB. Chronopharmaceutical drug delivery systems: hurdles, hype or hope? Adv Drug Deliv Rev. 2010;62(9-10):898-903. doi: 10.1016/j.addr.2010.04.010, PMID 20438781.
Kuila AN, Dhandapani NV, Bhowmik HI, Soni AB, Kumar KH. Chronotherapeutic drug delivery system: an emerging approach to treat circadian rhythmic related disease. Asian J Pharm Clin Res. 2018;11(8):15-20. doi: 10.22159/ajpcr.2018.v11i8.26169.
Patel SR. Floating pulsatile drug delivery system for chronotherapy. Int J Pharm Biol Sci. 2012;5(4):2264-71.
Reddy JR, Jyothsna MV, Saleem TM, Chetty CM. Review on: pulsatile drug delivery systems. J Pharm Sci Res. 2009 Dec 1;1(4):109.
Penhasi A, Gomberg M, Gomberg M, Inventors; Dexcel Pharma Technologies Ltd, Assignee. Specific time-delayed burst profile delivery system. United States patent application US; 2006 Dec 14;11(147):388.
Rathod S, Ram A, Thiru G. Colon targeted pulsatile drug delivery: a review. Pharmainfo Net. 2007;5(2):1.
Shanmugan P. Chronotherapeutic drug delivery systems. J Drug Metab Toxicol 2015;6(5). doi: 10.4172/2157-7609.1000194.
Amit K, Sonam R. Pulsatile drug delivery system: method and technology review. Int J Drug Dev Res. 2012;4(4):95-107.
Kraft M, Martin RJ. Chronobiology and chronotherapy in medicine. Disease-A-Month. 1995 Aug 1;41(8):506-75. doi: 10.1016/s0011-5029(95)90036-5, PMID 7628291.
Padmaxi B, Karwa P, Patel K, Sahidullah MM, Irshad PM. Formulation and evaluation of time-controlled drug delivery system of montelukast sodium. Int J Pharm Innov. 2012;2(3):1-2.
Qureshi J, Amir M, Ahuja A, Baboota S, Ali J. Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma. Indian J Pharm Sci. 2008 May;70(3):351-6. doi: 10.4103/0250-474X.43000, PMID 20046744.
Mahajan AN, Pancholi SS. Formulation and evaluation of timed delayed capsule device for Chronotherapeutic Delivery of terbutaline sulphate. Ars Pharm. 2009;50(4)215-23.
Sadaphal KP, Thakare VM, Gandhi BR, Tekade BW. Formulation and evaluation of pulsatile drug delivery system for chronobiological disorder: asthma. Int J Drug Deliv. 2011 Apr 1;3(2):348.
Khan Z, Pillay V, Choonara YE, du Toit LC. Drug delivery technologies for chronotherapeutic applications. Pharm Dev Technol. 2009 Dec 1;14(6):602-12. doi: 10.3109/10837450902922736, PMID 19883249.
Moon A, Kondawar M, Shah R. Formulation and evaluation of press-coated indomethacin tablets for pulsatile drug delivery system. J Pharm Res. 2011 Mar;4(3):564-6.
Cutolo M. Circadian rhythms in RA. Annals of the Rheumatic Diseases. 2003;62(7):593-6. doi: 10.1136/ard.62.7.593.
Sheetal J, Sudhakar CK, Jain S. Formulation and evaluation of floating pulsatile drug delivery system for chronotherapy of arthritis. Novel Sci Int J Pharm Sci. 2012;1(5):212-5.
Meena A, Kumar B, Suriyaprakash TNK, Senthamarai R. Development and evaluation of pulsatile drug delivery system of lornoxicam. Int J Pharm World Res. 2011;2(2):1-15.
Sharma S, Pawar A. Low-density multiparticulate system for pulsatile release of meloxicam. Int J Pharm. 2006 Apr 26;313(1-2):150-8. doi: 10.1016/j.ijpharm.2006.02.001, PMID 16540268.
Chauhan D, Shah SH. Formulation and evaluation of pulsatile drug delivery system of aceclofenac for treatment of rheumatoid arthritis. Int J Pharm Pharm Sci. 2012;4(3):507-12.
Kausalya J, Eswari JL, Priya SP, Rajan K, Vaijayanthi V, Rupenagunta A. Design, development and evaluation of pulsatile drug delivery of flurbiprofen microspheres. J Pharm Res. 2011 Jun;4(6):1614-6.
Patel KT, Mahajan AN, Saha DA. Studies in formulation development of chronotherapeutics dosage of the model drug. Scholars research library. Pharm Lett. 2011;3(4):227-40.
Li B, Zhu J, Zheng C, Gong W. A novel system for three-pulse drug release based on ’tablets in capsule’ device. Int J Pharm. 2008 Mar 20;352(1-2):159-64. doi: 10.1016/j.ijpharm.2007.10.043, PMID 18055142.
Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1987 Jun 11;316(24):1514-8. doi: 10.1056/NEJM198706113162405, PMID 3587281.
Bajpai M, Singh DC, Bhattacharya A, Singh A. Design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium. Indian J Pharm Sci. 2012 Mar;74(2):101-6. doi: 10.4103/0250-474X.103839, PMID 23325989.
Borgaonkar PA, Bushetti SS, Najmuddin M. Formulation and evaluation of pulsatile drug delivery system of metoprolol tartarate using core in cup tablet. Am J Med Med Sci. 2012;2(6):114-22. doi: 10.5923/j.ajmms.20120206.02.
Rao M, Parikh GN, Borate S, Ranpise A, Mandage Y, Thanki K. Design, evaluation and comparative study of pulsatile release from tablet and capsule dosage forms. Iranian J Pharmaceutical Science. Iranian Journal of Pharmaceutical Sciences. 2009: 5(3): 119-128
Gohel MC, Sumitra GM. Modulation of active pharmaceutical material release from a novel ‘tablet in capsule system’ containing an effervescent blend. J Control Release. 2002 Feb 19;79(1-3):157-64. doi: 10.1016/s0168-3659(01)00541-7, PMID 11853927.
Patil BS, Motagi AM, Kulkarni U, Hariprasanna RC, Patil SA. Development and evaluation of time-controlled pulsatile release lisinopril tablets. J Pharm Sci Bioscientific Res. 2012 Feb;2:30-5.
Latha K, Uhumwangho MU, Sunil SA, Srikanth MV, Murthy KR. Development of an optimised losartan potassium press-coated tablets for chronotherapeutic drug delivery. Trop J Pharm Res. 2011;10(5):551-8. doi: 10.4314/tjpr.v10i5.3.
Jagdale SC, Sali MS, Barhate AL, Loharkar JN, Chabukswar AR. Design and evaluation of enteric press-coated tablet for pulsatile delivery of atenolol. Int J Pharm World Res. 2010;1:1-5.
Patil AS, Dandagi PM, Masthiholimath VS, Gadad AP, Najwade BK. Development and characterization of chronomodulated drug delivery system of captopril. Int J Pharm Investig. 2011 Oct;1(4):227-33. doi: 10.4103/2230-973X.93010, PMID 23071948.
Goo RH, Moore JG, Greenberg E, Alazraki NP. Circadian variation in gastric emptying of meals in humans. Gastroenterology. 1987 Sep 1;93(3):515-8. doi: 10.1016/0016-5085(87)90913-9, PMID 3609660.
Youan BB. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J Control Release. 2004 Aug 27;98(3):337-53. doi: 10.1016/j.jconrel.2004.05.015, PMID 15312991.
Garg AK, Kumar A, Rani S, Singh M, Sharma A, Kumar R. Formulation and evaluation of chronotherapeutic pulsatile drug delivery system containing rabeprazole sodium. J Appl Pharm Sci. 2017 Feb 27;7(2):93-100.
Indria Muzib Y, Jitendra Kumar P, Sai Kishore V, Sandeep M, Suresh Babu M, Mallikharjunarao P. Design and development of chronopharmaceutical drug delivery of lansoprazole. J Pharm Res. 2014;8(2):123-9.
Arora D, Khurana B, Kaur S. Development and evaluation of pulsatile drug delivery system of pantoprazole sodium for the management of nocturnal acid breakthrough. Pharmaspire. 2019 Jan;11:29-33.
Jones PJ, Schoeller DA. Evidence for diurnal periodicity in human cholesterol synthesis. J Lipid Res. 1990 Apr 1;31(4):667-73. doi: 10.1016/S0022-2275(20)42835-4, PMID 2351871.
Sekhar PC. Formulation and evaluation of atorvastatin as pulsatile drug delivery system by using pulsincap technique. J Pharm Sci Res. 2019 Aug 1;11(8):2820-6.
Lekha GSS, Reddy DMS, Nagarjuna M. Formulation and evaluation of time-controlled pulsatile release rosuvastatin press-coated tablets. Saudi J Med Pharm Sci. 2022;8(9):444-54. doi: 10.36348/sjmps.2022.v08i09.003.
Kumar PJ, Muzib YI, Misra G. Formulation and evaluation of pulsatile drug delivery of lovastatin. Res J Pharm Technol. 2018 Jul 1;11(7):2797-803. doi: 10.5958/0974-360X.2018.00516.4.
Bae YH, Kim SW, Valuev LI, Inventors. Pulsatile drug delivery device using stimuli-sensitive hydrogel. United States Patent US. 1993 Jul 13;5(226):902.
Liu H, Sun T, Yu F, Zhao X, Guo H, Pan W. The investigation of the pharmacokinetics of pulsatile-release salbutamol sulfate with ph-sensitive ion exchange resin as the carriers in beagle dogs. Chem Pharm Bull (Tokyo). 2007;55(3):480-1. doi: 10.1248/cpb.55.480, PMID 17329898.
Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):852-82. doi: 10.1016/j.addr.2007.08.016, PMID 17900748.
Yadav D, Survase S, Kumar N. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation. Int J Pharm. 2011 Oct 31;419(1-2):121-30. doi: 10.1016/j.ijpharm.2011.07.026, PMID 21807081.
Portaluppi F, Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):952-65. doi: 10.1016/j.addr.2006.07.029, PMID 17675179.
Smolensky MH, Portaluppi F. Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am Heart J. 1999 Apr 1;137(4 Pt 2):S14-24. doi: 10.1016/s0002-8703(99)70392-3, PMID 10097242.
Kowanko IC, Pownall R, Knapp MS, Swannell AJ, Mahoney PG. Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. Br J Clin Pharmacol. 1981 May;11(5):477-84. doi: 10.1111/j.1365-2125.1981.tb01153.x, PMID 7272159.
Prasanthi N, Swathi G, Manikiran SS. Chronotherapeutic: a new vista in novel drug delivery systems. Int J Pharm Sci Rev Res. 2011;6:66-75.
Arora S, Ali J, Ahuja A, Baboota S, Qureshi J. Pulsatile drug delivery systems: an approach for controlled drug delivery. Indian J Pharm Sci. 2006;68(3):295-300.
Bussemer T, Dashevsky A, Bodmeier R. A pulsatile drug delivery system based on rupturable coated hard gelatin capsules. J Control Release. 2003 Dec 12;93(3):331-9. doi: 10.1016/j.jconrel.2003.08.012, PMID 14644583.
Crison JR, Siersma PR, Amidon GL. A novel programmable oral release technology for delivering drugs: human feasibility testing using gamma scintigraphy. In: Proceed Intern Symp Control Rel Bioact Mater. 1996. p. 23.
Chandani G, Ganesh B, Preeti K. A comprehensive review of pulsatile drug delivery system. J Pharm Innov. 2012 Sep 1;7(A):99.
Kalantzi LE, Karavas E, Koutris EX, Bikiaris DN. Recent advances in oral pulsatile drug delivery. Recent Pat Drug Deliv Formul. 2009 Jan 1;3(1):49-63. doi: 10.2174/187221109787158337, PMID 19149729.
Paul AD, Divyavani G, Pavani K, Gaffar MA, Thyagaraju K. Advanced drug delivery in designing of biological rhythm through pulsatile drug delivery system: current state of the art. Indo-American Journal of Pharmaceutical Research. 2019;8(1):1685-94.
Dalvadi H, Patel JK. Chronpharmaceutics, pulsatile drug delivery system as the current trend. Asian J Pharm Sci. 2010;5(5):204-30.
Survase S, Kumar N. Pulsatile drug delivery: current scenario. CRIPS. 2007 Apr;8(2):27-33.
Sershen S, West J. Implantable, polymeric systems for modulated drug delivery. Adv Drug Deliv Rev. 2002 Nov 5;54(9):1225-35. doi: 10.1016/s0169-409x(02)00090-x, PMID 12393303.
Patel Vipul P, Soniwala Moinuddin M. Pulsatile drug delivery system for treatment of various inflammatory disorder: a review. Int J Drug Dev Res. 2012;4(3):67-87.
Gandhi BR, Mundada AS, Gandhi PP. Chronopharmaceutics: as a clinically relevant drug delivery system. Drug Deliv. 2011 Jan 1;18(1):1-18. doi: 10.3109/10717544.2010.509358, PMID 21138394.
Nagar M, Singhai S, Chopra VS, Gautam N, Trivedi P. Chronotropic systems; an emerging trend in drug delivery for pulsed release in chronopharmacotherapy. Int J Pharm Clin Res. 2010;2:9-19.
Mandal AS, Biswas N, Karim KM, Guha A, Chatterjee S, Behera M. Drug delivery system based on chronobiology-a review. J Control Release. 2010 Nov 1;147(3):314-25. doi: 10.1016/j.jconrel.2010.07.122, PMID 20691738.
Murdan S. Electro-responsive drug delivery from hydrogels. J Control Release. 2003 Sep 19;92(1-2):1-17. doi: 10.1016/s0168-3659(03)00303-1, PMID 14499181.
Everett HE. Apparatus and method for implanted self-powered medication dispensing. U.S. Patent 4003379A; 1977.
Gordon LA. Pulsatile drug delivery system. U.S. Patent 5229131A; 1993.
Chih Ming C. Cooper city F. Multiparticulate pulsatile drug delivery system. U.S. Patent 5260068A; 1993.
Chen CM. Multiparticulate pulsatile drug delivery system. U.S. Patent 5508040 A; 1996.
Barry M, Yomtov MMA, Stephen J, Herman AMA. Medical device for controlled drug delivery and cardiac monitoring or stimulation. U.S. Patent 7917208 B2; 2011.
Vinay KS, Javed H, Habil FK. Composition for pulsatile delivery of diltiazem and process of manufacture. U.S. Patent 6635277 B2; 2003.
Phillip J, Percel KS, Vishnupad GM, Venkatesh DYL. Timed pulsatile drug delivery systems. U.S. Patent 7048945 B2; 2006.
Percel PJ, Vyas NH, Vishnupad KS, Venkatesh GM. Pulsatile release histamine H2 antagonist dosage form. U.S. Patent 6663888; 2003.
Isabelle R, Giovanna M. Coated diclofenac tablets. U.S. Patent 7972625B2; 2011.
Beth AB, Xiaodi GDW, Kimberly F. Oral pulsed dose drug delivery system. U.S. Patent 6605300B1; 2003.
Phillip PT, Krishna S, Vishnupad D, Gopi MV, Dayton OH. Timed pulsatile drug delivery systems. U.S. Patent 6627223B2; 2003.
Percel PJ, Vyas NH, Vishnupad KS, Venkatesh GM. Pulsatile release histamine H2 antagonist dosage form. U. S. Patent 6663888; 2003.
Vinay KS, Long Valley NJ. Process for the pulsatile delivery of diltiazem HCl and product produced thereby. U. S. Patent 5914134A; 1999.
Sharma V. Pulsatile release dosage form. W2015028972; 2015.
Published
How to Cite
Issue
Section
Copyright (c) 2023 GOMATHI J., VEERALAKSHMI B., FARZANA AFFRIN M. F.
This work is licensed under a Creative Commons Attribution 4.0 International License.
